HIV/AIDS progression, possibly modifying vitamin D levels, which could be relevant for the pathogenesground: HIV/AIDS progression is linked to vitamin D, which is regulated by several key cytochromes P450 (CYP). Single nucleotide polymorphisms (SNPs) in CYP genes influence vitamin D metabolism and serum levels. The objective of this study was to evaluate the association between CYP SNPs and the clinical AIDS progression in antiretroviral treatment (ART)-naïve HIV-infected patients.
We performed a retrospective study in 661 ART-naïve HIV-infected patients who were stratified by their AIDS progression pattern (181 long-term non-progressors (LTNPs), 332 moderate progressors (MPs), and 148 rapid progressors (RPs)). Four CYP SNPs (CYP2R1 rs10500804, CYP2R1 rs1993116, CYP27B1 rs10877012, and CYP24A1 rs6013897) were genotyped using Agena Bioscience’s MassARRAY platform. Correction for multiple testing was performed using the false discovery rate (FDR; Benjamini-Hochberg procedure).
The adjusted regression showed a significant association only for CYP27B1 rs10877012 SNP. When analyzing all HIV patients, the rs10877012 T allele was protective against AIDS progression (ordinal outcome) under the dominant (adjusted OR (aOR)=0.69; p=0.021) and additive (aOR)=0.75; p=0.025) inheritance models. When analyzing LTNPs versus RPs, the rs10877012 T allele also showed a significant protective association under the dominant (aOR=0.45; p=0.004) and additive (aOR=0.54; p=0.008) inheritance models. P-values remained significant after correcting by multiple comparisons only for the comparison of LTNPs versus RPs (extreme phenotypes).
The CYP27B1 rs10877012 T allele was linked to non-AIDS progression in ART-naïve HIV-infected patients. The rs10877012 SNP seems to have an impact on the clinical AIis of HIV infection.